September 30, 2022
Loading...
You are here:  Home  >  Health Care & Life Science  >  Current Article

Sientra waits for production to resume amid stock crash

IN THIS ARTICLE

Sientra officials celebrate being listed on the Nasdaq after an IPO in October 2014. The bottom has fallen out from under Sientra and the Goleta-based breast implant manufacturer is bleeding cash as it waits for approval to resume production. Exactly one month ago, the company stunned Wall Street with news that regulators found contaminating particles…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.